These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6185233)

  • 1. In vivo tyrosine phosphorylations of the Abelson virus transforming protein are absent in its normal cellular homolog.
    Ponticelli AS; Whitlock CA; Rosenberg N; Witte ON
    Cell; 1982 Jul; 29(3):953-60. PubMed ID: 6185233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein phosphorylation at tyrosine residues in v-abl transformed mouse lymphocytes and fibroblasts.
    Saggioro D; Ferracini R; Di Renzo MF; Naldini L; Chieco-Bianchi L; Comoglio PM
    Int J Cancer; 1986 Apr; 37(4):623-8. PubMed ID: 2420727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation induced by Abelson murine leukemia virus involves production of a polypeptide growth factor.
    Twardzik DR; Todaro GJ; Marquardt H; Reynolds FH; Stephenson JR
    Science; 1982 May; 216(4548):894-7. PubMed ID: 6177040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
    Engelman A; Rosenberg N
    J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abelson murine leukemia virus transformation-defective mutants with impaired P120-associated protein kinase activity.
    Reynolds FH; Van de Ven WJ; Stephenson JR
    J Virol; 1980 Nov; 36(2):374-86. PubMed ID: 6253663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of the Abelson murine leukemia virus transforming protein.
    Witte ON; Ponticelli A; Gifford A; Baltimore D; Rosenberg N; Elder J
    J Virol; 1981 Sep; 39(3):870-8. PubMed ID: 6270355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed deletions of Abelson murine leukemia virus define 3' sequences essential for transformation and lethality.
    Watanabe SM; Witte ON
    J Virol; 1983 Mar; 45(3):1028-36. PubMed ID: 6300444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity.
    Witte ON; Goff S; Rosenberg N; Baltimore D
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4993-7. PubMed ID: 6254050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.
    Prywes R; Foulkes JG; Rosenberg N; Baltimore D
    Cell; 1983 Sep; 34(2):569-79. PubMed ID: 6193890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the Abelson virus protein functions in vivo as a protein kinase that phosphorylates tyrosine.
    Sefton BM; Hunter T; Raschke WC
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1552-6. PubMed ID: 6262813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50.
    Rotter V; Witte ON; Coffman R; Baltimore D
    J Virol; 1980 Nov; 36(2):547-55. PubMed ID: 6159484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of the Abelson murine leukemia virus transforming gene.
    Wang JY; Prywes R; Baltimore D
    Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.
    Rosenberg N; Witte ON
    J Virol; 1980 Jan; 33(1):340-8. PubMed ID: 6245237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine.
    Witte ON; Dasgupta A; Baltimore D
    Nature; 1980 Feb; 283(5750):826-31. PubMed ID: 6244493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
    Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
    J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gag-derived but not abl-derived determinants are exposed on the surface of Abelson virus-transformed cells.
    Schiff-Maker L; Rosenberg N
    Virology; 1986 Oct; 154(2):286-301. PubMed ID: 3020782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.